midazolam has been researched along with flurazepam in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (37.84) | 18.7374 |
| 1990's | 19 (51.35) | 18.2507 |
| 2000's | 3 (8.11) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Loeffler, PM | 1 |
| Dolin, SJ; Little, HJ; Patch, TL; Rabbani, M; Taberner, PV | 1 |
| Amidon, GL; Goldberg, A; Lui, CY | 1 |
| Chernik, DA; Johnson, LC; Sateia, MJ | 1 |
| Deutsch, SI; Huntzinger, JA; Mastropaolo, J; Novitzki, MR; Rosse, RB | 1 |
| Chernik, DA; Johnson, LC; Kanitra, L | 1 |
| Chen, D; Moskowitz, H | 1 |
| Judd, LL; Linnoila, M; Roehrs, T; Roth, T | 1 |
| Hauri, P; Kripke, D; Roehrs, T; Sateia, MJ | 1 |
| Chen, D; Chernik, DA; Ellinwood, E; Hauri, P; Johnson, LC; Judd, LL; Kripke, DF; Linnoila, M; Moskowitz, H; Roth, T | 1 |
| Ancoli-Israel, S; Hauri, P; Kripke, DF; Roth, T | 1 |
| Linnoila, M; Moskowitz, H; Roehrs, T | 1 |
| Ellinwood, E; Judd, LL; McAdams, LA | 1 |
| Ellinwood, E; Linnoila, M; Marsh, G | 1 |
| Chernik, DA; Hauri, P; Johnson, LC | 1 |
| Ikeda, H; Robbins, J | 2 |
| Rosenberg, HC; Tietz, EI; Zhang, H | 1 |
| Bixler, EO; Jacoby, JA; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Alonso, R; Astier, H; Tapia-Arancibia, L | 1 |
| Gale, R; Little, HJ; Nutt, DJ; Sellars, N; Taylor, SC | 1 |
| Hicks, TP; Jang, EK; Oka, JI | 1 |
| Bakker, C; Eichelkraut, W; Göbel, R; Greenblatt, DJ; Hahn, N; Ochs, HR | 1 |
| Bixler, EO; Kales, A; Kales, JD; Soldatos, CR | 1 |
| Lorens, SA; Sainati, SM | 1 |
| Breimer, DD; Jochemsen, R | 1 |
| Bichard, AR; Little, HJ | 1 |
| Borbély, AA | 1 |
| Owens, C; Vasiliades, J | 1 |
| Chiu, TH; Rosenberg, HC; Wu, Y | 1 |
| Baker, AB; Ballantyne, JA; Kumar, K | 1 |
| MacDonald, JF; McAdam, LC; Orser, BA | 1 |
| Briellmann, TA; Dussy, FE; Hamberg, C | 1 |
4 review(s) available for midazolam and flurazepam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral benzodiazepines and conscious sedation: a review.
Topics: Administration, Oral; Alprazolam; Ambulatory Surgical Procedures; Anti-Anxiety Agents; Conscious Sedation; Diazepam; Flurazepam; Humans; Lorazepam; Midazolam; Oxazepam; Premedication; Receptors, GABA-A; Temazepam; Triazolam | 1992 |
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
Topics: Chronic Disease; Double-Blind Method; Flurazepam; Humans; Long-Term Care; Midazolam; Psychomotor Performance; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
13 trial(s) available for midazolam and flurazepam
| Article | Year |
|---|---|
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
Topics: Chronic Disease; Double-Blind Method; Flurazepam; Humans; Long-Term Care; Midazolam; Psychomotor Performance; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Effects of flurazepam and midazolam on sleep and next-day performance in chronic insomniacs: report of a multicenter study.
Topics: Flurazepam; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders | 1990 |
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: methodology.
Topics: Adult; Affect; Arousal; Attention; Electroencephalography; Female; Flurazepam; Half-Life; Humans; Male; Midazolam; Middle Aged; Pilot Projects; Psychomotor Performance; Signal Processing, Computer-Assisted; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Drug performance sensitivity: a pilot study.
Topics: Adult; Affect; Arousal; Attention; Flurazepam; Humans; Male; Midazolam; Neuropsychological Tests; Pilot Projects; Psychomotor Performance; Reaction Time | 1990 |
Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam.
Topics: Adult; Affect; Arousal; Electroencephalography; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Reaction Time; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.
Topics: Adult; Double-Blind Method; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders | 1990 |
A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary.
Topics: Adult; Affect; Arousal; Chronic Disease; Double-Blind Method; Flurazepam; Humans; Midazolam; Psychomotor Performance; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam.
Topics: Adult; Arousal; Dose-Response Relationship, Drug; Electroencephalography; Female; Flurazepam; Humans; Longitudinal Studies; Male; Midazolam; Middle Aged; Reaction Time; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam.
Topics: Adult; Arousal; Attention; Dose-Response Relationship, Drug; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Psychomotor Performance; Reaction Time; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam.
Topics: Adult; Affect; Arousal; Attention; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Neuropsychological Tests; Problem Solving; Sleep Initiation and Maintenance Disorders | 1990 |
Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.
Topics: Adult; Arousal; Attention; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions.
Topics: Arousal; Attention; Double-Blind Method; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Psychomotor Performance; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1990 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Half-Life; Humans; Lorazepam; Midazolam; Middle Aged; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Time Factors; Triazolam | 1985 |
22 other study(ies) available for midazolam and flurazepam
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Differential interactions between benzodiazepines and the dihydropyridines, nitrendipine and Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthesia; Animals; Ataxia; Benzodiazepines; Brain; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Flurazepam; GABA-A Receptor Antagonists; Isoquinolines; Male; Mice; Midazolam; Nitrendipine; Seizures | 1991 |
Intranasal absorption of flurazepam, midazolam, and triazolam in dogs.
Topics: Absorption; Administration, Intranasal; Administration, Oral; Animals; Chromatography, Gas; Dogs; Flurazepam; Intestinal Absorption; Male; Midazolam; Nasal Mucosa; Triazolam | 1991 |
Profound stress-induced alterations in flurazepam's antiseizure efficacy can be attenuated.
Topics: Animals; Carbolines; Clonazepam; Cold Temperature; Diazepam; Dose-Response Relationship, Drug; Electroshock; Flumazenil; Flurazepam; Male; Mice; Mice, Inbred Strains; Midazolam; Seizures; Stress, Psychological | 1990 |
Benzodiazepines and the mammalian retina. I. Autoradiographic localisation of receptor sites and the lack of effect on the electroretinogram.
Topics: Animals; Benzodiazepines; Body Weight; Cats; Flumazenil; Flunitrazepam; Flurazepam; Membrane Potentials; Midazolam; Photic Stimulation; Rats; Receptors, GABA-A; Retina | 1989 |
Benzodiazepines and the mammalian retina. II. Actions on retinal ganglion cells.
Topics: Action Potentials; Animals; Benzodiazepines; Cats; Female; Flumazenil; Flurazepam; Male; Midazolam; Photic Stimulation; Rats; Receptors, GABA-A; Retina; Retinal Ganglion Cells | 1989 |
Injection of benzodiazepines but not GABA or muscimol into pars reticulata substantia nigra suppresses pentylenetetrazol seizures.
Topics: Animals; Benzodiazepines; Flurazepam; gamma-Aminobutyric Acid; Male; Midazolam; Muscimol; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Substantia Nigra | 1989 |
Evidence for a role of central type benzodiazepine receptors in the inhibition of the thyrotropin-releasing hormone-induced thyrotropin release from rat perifused pituitaries.
Topics: Animals; Anti-Anxiety Agents; Chlordiazepoxide; Diazepam; Flurazepam; In Vitro Techniques; Male; Midazolam; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; Receptors, GABA-A; Thyrotropin; Thyrotropin-Releasing Hormone | 1986 |
Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142.
Topics: Animals; Anti-Anxiety Agents; Appetite Depressants; Carbolines; Drug Synergism; Drug Tolerance; Flurazepam; Kindling, Neurologic; Male; Mice; Mice, Inbred Strains; Midazolam; Time Factors | 1988 |
Benzodiazepine receptor involvement in the control of receptive field size and responsiveness in primary somatosensory cortex.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Cats; Diazepam; Female; Flumazenil; Flurazepam; gamma-Aminobutyric Acid; Male; Midazolam; Neurons; Receptors, GABA-A; Sensory Thresholds; Somatosensory Cortex; Touch | 1986 |
Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
Topics: Administration, Oral; Animals; Digestive System; Flurazepam; Liver; Midazolam; Swine | 1987 |
Early morning insomnia with rapidly eliminated benzodiazepines.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders; Triazolam | 1983 |
Intra-raphe benzodiazepines enhance rat locomotor activity: interactions with GABA.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Bicuculline; Brain Stem; Chlordiazepoxide; Dose-Response Relationship, Drug; Flurazepam; gamma-Aminobutyric Acid; Male; Midazolam; Motor Activity; Muscimol; Raphe Nuclei; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Synaptic Transmission | 1983 |
Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Bromazepam; Child; Clobazam; Flunitrazepam; Flurazepam; Humans; Hydroxylation; Kinetics; Lorazepam; Midazolam; Middle Aged; Nitrazepam; Nordazepam | 1984 |
Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
Topics: Anesthesia, General; Anesthetics; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Chlordiazepoxide; Convulsants; Diazepam; Flumazenil; Flurazepam; Male; Mice; Mice, Inbred Strains; Midazolam; Reflex | 1984 |
Ambulatory motor activity monitoring to study the timecourse of hypnotic action.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flunitrazepam; Flurazepam; Humans; Hypnotics and Sedatives; Midazolam; Motor Activity; Sleep; Temazepam; Time Factors; Triazolam | 1984 |
Determination of midazolam in serum by gas chromatography with a nitrogen-selective detector.
Topics: Benzodiazepines; Flurazepam; Gas Chromatography-Mass Spectrometry; Humans; Midazolam | 1980 |
Rapid down-regulation of [3H]zolpidem binding to rat brain benzodiazepine receptors during flurazepam treatment.
Topics: Animals; Brain Chemistry; Down-Regulation; Flurazepam; Hypnotics and Sedatives; In Vitro Techniques; Male; Membranes; Midazolam; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 1995 |
Determination of droperidol in plasma by liquid chromatography.
Topics: Adjuvants, Anesthesia; Chromatography, High Pressure Liquid; Droperidol; Flurazepam; Half-Life; Heart Valve Diseases; Humans; Midazolam; Myocardial Revascularization; Nitrazepam | 1996 |
Isobolographic analysis of the interactions between midazolam and propofol at GABA(A) receptors in embryonic mouse neurons.
Topics: Anesthetics, Intravenous; Animals; Anti-Anxiety Agents; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Flurazepam; Hippocampus; Membrane Potentials; Mice; Midazolam; Neurons; Patch-Clamp Techniques; Propofol; Receptors, GABA-A | 1998 |
Quantification of benzodiazepines in whole blood and serum.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chromatography, High Pressure Liquid; Flunitrazepam; Flurazepam; Forensic Toxicology; Humans; Mass Spectrometry; Midazolam; Molecular Structure; Serum | 2006 |